Oncolytics Biotech (NASDAQ:ONCY) Downgraded by Zacks Investment Research to Hold

Oncolytics Biotech} stock has undergone multiple analysts rating changes in the recent past.  Oncolytics Biotech Downgraded by Zacks Investment Research on 10/19/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Oncolytics Biotech (NASDAQ:ONCY) Downgraded by Zacks Investment Research to Hold